Alumni Companies

TippingPoint Biosciences Raises $4.5M Seed to Drug Hidden Epigenetic Targets in Deadly Pediatric Brain Cancer

Unnatural Products gets $45M to test decadelong work on macrocyclic peptides

Sift Biosciences Announces Oversubscribed $3.7M Pre-seed Financing to Advance Next-generation T-cell Immunotherapy Platform

Sift Biosciences, a UC Berkeley spinout developing a next-generation peptide immunotherapy platform that integrates AI, metagenomics, and high-throughput immune profiling,...

AstraZeneca, Algen Biotechnologies pen $555M AI pact for immunology targets

Inflammatix Receives FDA Clearance for First-in-Class TriVerity™ Test

Using precise measurements of a patient’s immune response, TriVerity combines highly accurate bacterial-viral infection scoring with an all-cause illness severity...

Argenx signs $1.5B pact to turn Unnatural Products’ macrocyclic peptides to ‘undruggable’ targets

Argenx wants to get in on the macrocyclic peptide action, penning a deal worth $1.5 billion in biobucks with Californian...

GE HealthCare and Raydiant Oximetry accelerate innovation in fetal oxygen saturation technology

The companies plan to co-develop solutions that support the integration of Raydiant Oximetry’s fetal pulse oximetry technology into GE HealthCare’s...

HOPO Therapeutics Awarded Up to $226 Million from BARDA for Advanced Development of its Oral Decorporation Agent for Heavy Metal Toxicity

The funds will be used to advance development of the drug candidate HOPO-101 through registrational studies as a medical countermeasure...

X-Therma’s $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation